box10.gif (1299 bytes)

 

 

 

 

 

 

Medical imaging

Olympus launches unit to serve Canadian market

MARKHAM, Ont. – Olympus, a precision technology leader designing and delivering imaging solutions in healthcare, life science and photography, has announced the launch of Olympus Canada Inc. to provide direct services to Olympus’ Canadian customers in the medical, surgical, scientific, and industrial markets.

Glen Stalter, 45, has been appointed the first Executive Vice President and Chief Operating Officer of Olympus Canada.

Over the past 58 years, Olympus and its customers were served by a distributor in Canada. In order to help ensure a smooth transition, 98 percent of the former distributor’s sales and support staff have become employees of Olympus Canada. Customers will also benefit from the resources of the global Olympus network, including greater access to educational support, international programs and courses, and the opportunity to partner with Olympus for research projects and advancements in clinical endoscopy applications.

“With a current endoscopy market share of nearly 80 percent and Olympus’ strong growth momentum in Canada, the launch of Olympus Canada comes at the right time,” said F. Mark Gumz, President of Olympus Canada. Gumz, who is also President and Chief Operating Officer of Olympus America Inc., added, “Glen Stalter has been involved in every aspect of transitioning the business to the new company. He is a consummate professional, and I am pleased he is Olympus Canada’s first COO.”

Stalter has been an Olympus employee for nearly 13 years. Over the past six years, he served as the executive of various corporate responsibilities at Olympus America, including Finance, Operations, Healthcare Services, and Financial Services.

“I would like to thank our Canadian customers for their support of the Olympus line during the last half century,” said Stalter. “We look forward to broadening our offerings with enhanced service lines and the synergies now possible by working with our neighboring Olympus sister companies.”

Olympus Canada will continue supporting the adoption of new Olympus products in the Canadian marketplace, such as the EVIS EXERA II 180, the world’s first endoscope platform to deliver high-definition television (HDTV)and Narrow Band Imaging (NBI) technologies to enhance visualization during gastroenterological procedures.

The universal platform also integrates surgical endoscopy, such as the HD EndoEYE surgical videoscopes and medical endoscopy, into one complete system for multiple specialties, e.g., general surgery, gastroenterology, urology and gynecology.

Olympus Canada will also introduce additional Olympus products and services to provide total solutions to Canadian GI facilities that increase efficiency and clinical outcomes. Among the new offerings is EndoSite Consulting, a comprehensive collection of professional services for hospital GI labs, private endoscopy clinics and office endoscopy practices.

Olympus Financial Services provides cost-effective, balance-sheet sensitive solutions that enable healthcare professionals to maximize market share, revenues and profits through the acquisition of Olympus instrumentation, coupled with prudent asset management.

Another new service offered by Olympus Canada is Olympus University, an extensive selection of endoscopy programs, providing continued medical education (CME) and contact hour accredited live courses to physicians, surgeons, nurses, technicians, biomedical engineers, administrators and materials managers to further their knowledge of the industry.

Olympus willalso seek partnerships with Canadian healthcare professionals to develop new product prototypes with Olympus research and development, enabling customers to impact products in development by providing early feedback, and to use the latest Olympus technologies earlier.

Donations to Canadian Colorectal Cancer Groups:

On the occasion of its launch, Olympus Canada is donating Cdn$15,000 to each the Colorectal Cancer Association of Canada (CCAC) and Colorectal Cancer Screening Initiative Foundation (CCSIF). Stalter will present cheques to each organization at a special event at Ontario Science Centre in Toronto.

“Olympus is committed to increasing the public’s awareness for the need to be screened, and at the same time, we will be working together with our customers to find ways to improve efficiencies so that more Canadians can be screened,” added Stalter. “It’s our mission.”

This year, 20,000 Canadians will be diagnosed with colorectal cancer, the second-leading cause of death from cancer, and 8,600 will die of it, according to the Canadian Cancer Society.

About Olympus Canada
Olympus is a precision technology leader, designing and delivering innovative solutions in healthcare, life science and photography. Olympus Canada works collaboratively with its customers and its ultimate parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
• Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
• Advanced clinical and research microscopes;
• Industrial imaging, including remote inspection, industrial microscopy and real-time manufacturing inspection.
For more information, visit www.olympuscanada.com.

 

HOME - CURRENT ISSUE - ABOUT US - SUBSCRIBE - ADVERTISE - ARCHIVES - CONTACT US - EVENTS - LINKS